AirSculpt Technologies, Inc. (AIRS)
USD 1.68
(5.35%)
USD 1.68
(5.35%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.48 Million USD | 621.03% |
| 2022 | -3.46 Million USD | -121.98% |
| 2021 | 15.76 Million USD | 57.16% |
| 2020 | 10.03 Million USD | 1413.27% |
| 2019 | 663 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -790 Thousand USD | -107.17% |
| 2024 Q1 | 11.01 Million USD | 311.39% |
| 2023 Q2 | 5.36 Million USD | 204.31% |
| 2023 Q1 | 1.76 Million USD | 134.56% |
| 2023 FY | 18.05 Million USD | 621.03% |
| 2023 Q4 | 2.67 Million USD | 180.42% |
| 2023 Q3 | 955 Thousand USD | -82.19% |
| 2022 Q1 | -1.17 Million USD | 90.45% |
| 2022 Q3 | -1.38 Million USD | -135.0% |
| 2022 Q2 | 3.96 Million USD | 438.43% |
| 2022 FY | -3.46 Million USD | -121.98% |
| 2022 Q4 | -5.09 Million USD | -267.56% |
| 2021 Q2 | 11.19 Million USD | 55.38% |
| 2021 FY | 15.76 Million USD | 57.16% |
| 2021 Q4 | -12.25 Million USD | -227.41% |
| 2021 Q3 | 9.62 Million USD | -14.09% |
| 2021 Q1 | 7.2 Million USD | 15.39% |
| 2020 Q4 | 6.24 Million USD | 81.15% |
| 2020 Q3 | 3.44 Million USD | 1934.22% |
| 2020 Q2 | 169.5 Thousand USD | 0.0% |
| 2020 Q1 | 169.5 Thousand USD | 0.0% |
| 2020 FY | 10.03 Million USD | 1413.27% |
| 2019 FY | 663 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 98.128% |
| Addus HomeCare Corporation | 90.95 Million USD | 89.574% |
| Amedisys, Inc. | 156.39 Million USD | 93.936% |
| American Oncology Network, Inc. | -49.15 Million USD | 119.292% |
| Astrana Health, Inc. | 84.61 Million USD | 88.793% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -17.48% |
| IMAC Holdings, Inc. | -6.37 Million USD | 248.741% |
| biote Corp. | 28.65 Million USD | 66.909% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 177.072% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 91.587% |
| COMPASS Pathways plc | -136.91 Million USD | 106.926% |
| DocGo Inc. | 15.05 Million USD | 37.011% |
| The Ensign Group, Inc. | 255.36 Million USD | 96.287% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 84.793% |
| InnovAge Holding Corp. | -23.18 Million USD | 140.91% |
| Assure Holdings Corp. | -20.08 Million USD | 147.221% |
| The Joint Corp. | -2.07 Million USD | 557.434% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 105.014% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 160.387% |
| ModivCare Inc. | -139.94 Million USD | 106.776% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -22349.221% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 210.871% |
| Option Care Health, Inc. | 314.59 Million USD | 96.986% |
| P3 Health Partners Inc. | -167.86 Million USD | 105.649% |
| P3 Health Partners Inc. | -167.86 Million USD | 105.649% |
| The Pennant Group, Inc. | 25.16 Million USD | 62.323% |
| Surgery Partners, Inc. | 328 Million USD | 97.109% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 428.404% |
| Talkspace, Inc. | -23.2 Million USD | 140.859% |
| Talkspace, Inc. | -23.2 Million USD | 140.859% |
| The Oncology Institute, Inc. | -77.01 Million USD | 112.313% |
| The Oncology Institute, Inc. | -77.01 Million USD | 112.313% |